diff --git a/inbox/queue/2026-04-21-apotex-fda-tentative-approval-generic-semaglutide.md b/inbox/archive/health/2026-04-21-apotex-fda-tentative-approval-generic-semaglutide.md
similarity index 98%
rename from inbox/queue/2026-04-21-apotex-fda-tentative-approval-generic-semaglutide.md
rename to inbox/archive/health/2026-04-21-apotex-fda-tentative-approval-generic-semaglutide.md
index d57172f32..2fbfa8048 100644
--- a/inbox/queue/2026-04-21-apotex-fda-tentative-approval-generic-semaglutide.md
+++ b/inbox/archive/health/2026-04-21-apotex-fda-tentative-approval-generic-semaglutide.md
@@ -7,9 +7,12 @@ date: 2026-04-10
 domain: health
 secondary_domains: []
 format: press-release
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-04-21
 priority: medium
 tags: [GLP-1, semaglutide, generic, FDA, biosimilar, patent, access]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content